Description: Inotiv, Inc. is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market.
Home Page: www.inotivco.com
NOTV Technical Analysis
2701 Kent Avenue
West Lafayette,
IN
47906-1382
United States
Phone:
765 463 4527
Officers
| Name | Title |
|---|---|
| Mr. Robert W. Leasure Jr. | Pres, CEO & Director |
| Ms. Beth A. Taylor CPA | Sr. VP of Fin. & CFO |
| Dr. John E. Sagartz D.V.M., DiplomateACVP, DVM, Ph.D. | Chief Strategy Officer & Director |
| Dr. Peter T. Kissinger | Founder, Chairman Emeritus & Scientific Advisor |
| Mr. Brennan Freeman | VP of Fin., Principal Accounting Officer & Corp. Controller |
| Mr. Mo Dastagir | Chief Technology Officer |
| Ms. Fernanda Beraldi | Gen. Counsel & Corp. Sec. |
| Ms. Kimberly Beaty | Sr. Director of Marketing |
| Mr. William D. Pitchford | Chief HR Officer |
| Mr. John Gregory Beattie DSA | Chief Operating Officer of Discovery and Safety Assessment |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Life Sciences Tools & Services |
| GIC Sub-Industry: | Life Sciences Tools & Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.1918 |
| Price-to-Sales TTM: | 0.2714 |
| IPO Date: | 1997-11-25 |
| Fiscal Year End: | September |
| Full Time Employees: | 541 |